KLK3 and metastatic neoplasm: We recommended restarting hormonal therapy if there was clinical, radiological or bone scan evidence of metastatic disease or a rapid PSA doubling time (⩽6 months); additionally, some patients preferred immediate to deferred hormonal therapy for PSA only failure.